The Gynecologic Oncology session at GWC 2026 is dedicated to the diagnosis, treatment, and research of cancers affecting the female reproductive system—including cervical, ovarian, endometrial, vulvar, and vaginal cancers. As cancer care becomes increasingly personalized, this session will cover genomic profiling, precision therapies, immunotherapy, and novel screening strategies such as HPV DNA testing. It also addresses the psychosocial dimensions of survivorship and palliative care. This session invites oncologists, gynecologic surgeons, radiation oncologists, pathologists, clinical trialists, and research scientists committed to advancing cancer detection and treatment and improving the lives of women globally.